Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) EBT Margin (2023 - 2025)

Camp4 Therapeutics' EBT Margin history spans 3 years, with the latest figure at 3467.24% for Q4 2025.

  • For Q4 2025, EBT Margin fell 143043.0% year-over-year to 3467.24%; the TTM value through Dec 2025 reached 1440.28%, up 647582.0%, while the annual FY2025 figure was 1445.77%, 649764.0% up from the prior year.
  • EBT Margin for Q4 2025 was 3467.24% at Camp4 Therapeutics, down from 1663.9% in the prior quarter.
  • Across five years, EBT Margin topped out at 16336.14% in Q4 2023 and bottomed at 3467.24% in Q4 2025.
  • The 3-year median for EBT Margin is 1561.09% (2025), against an average of 1144.98%.
  • The largest annual shift saw EBT Margin plummeted -1837295bps in 2024 before it tumbled -143043bps in 2025.
  • A 3-year view of EBT Margin shows it stood at 16336.14% in 2023, then tumbled by -112bps to 2036.81% in 2024, then crashed by -70bps to 3467.24% in 2025.
  • Per Business Quant, the three most recent readings for CAMP's EBT Margin are 3467.24% (Q4 2025), 1663.9% (Q3 2025), and 840.01% (Q2 2025).